The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling.
Ailin LuoZifeng WuShan LiCindy B McReynoldsDi WangHanyu LiuChaoli HuangTeng HeXinying ZhangYuanyuan WangCunming LiuBruce D HammockKenji HashimotoChun YangPublished in: Journal of translational medicine (2023)
sEH underlies the mechanisms of the comorbidity of chronic pain and depression and that TPPU exerts a beneficial effect on anhedonia behaviors in a pain model via AHR and TSPO signaling.